WallStreetZenWallStreetZen

NYSE: DLB
Dolby Laboratories Inc Stock Forecast, Predictions & Price Target

Analyst price target for DLB

Based on 1 analyst offering 12 month price targets for Dolby Laboratories Inc.
Min Forecast
$98.00+22.64%
Avg Forecast
$98.00+22.64%
Max Forecast
$98.00+22.64%

Should I buy or sell DLB stock?

Based on 1 analyst offering ratings for Dolby Laboratories Inc.
Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their DLB stock forecasts and price targets.

DLB stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-01-31

1 of 1

Forecast return on equity

Is DLB forecast to generate an efficient return?

Forecast return on assets

Is DLB forecast to generate an efficient return on assets?

DLB revenue forecast

What is DLB's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$1.3B+1.33%
Avg 2 year Forecast
$1.4B+6.21%
Avg 3 year Forecast
$1.5B+16.85%
DLB's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

DLB revenue growth forecast

How is DLB forecast to perform vs Specialty Business Services companies and vs the US market?
Company
3.91%
Industry
4.68%
Market
9.03%
DLB's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
DLB's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

DLB vs Specialty Business Service Stocks

TickerPricePrice TargetUp/downsideConsensus
DLB$79.91$98.00+22.64%Strong Buy
ARMK$32.33$33.20+2.69%Buy
MMS$80.63N/AN/A
CBZ$75.53$63.00-16.59%Hold
UNF$163.82$183.67+12.12%Hold

Dolby Laboratories Stock Forecast FAQ

Is Dolby Laboratories Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NYSE: DLB) stock is to Strong Buy DLB stock.

Out of 1 analyst, 1 (100%) are recommending DLB as a Strong Buy, 0 (0%) are recommending DLB as a Buy, 0 (0%) are recommending DLB as a Hold, 0 (0%) are recommending DLB as a Sell, and 0 (0%) are recommending DLB as a Strong Sell.

If you're new to stock investing, here's how to buy Dolby Laboratories stock.

What is DLB's revenue growth forecast for 2024-2026?

(NYSE: DLB) Dolby Laboratories's forecast annual revenue growth rate of 3.91% is not forecast to beat the US Specialty Business Services industry's average forecast revenue growth rate of 4.68%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.03%.

Dolby Laboratories's revenue in 2024 is $1,280,397,000.On average, 3 Wall Street analysts forecast DLB's revenue for 2024 to be $124,008,087,824, with the lowest DLB revenue forecast at $123,416,168,111, and the highest DLB revenue forecast at $124,408,276,398. On average, 3 Wall Street analysts forecast DLB's revenue for 2025 to be $129,975,074,368, with the lowest DLB revenue forecast at $127,554,731,580, and the highest DLB revenue forecast at $132,611,807,634.

In 2026, DLB is forecast to generate $143,002,182,570 in revenue, with the lowest revenue forecast at $142,676,258,749 and the highest revenue forecast at $143,328,106,390.

What is DLB's forecast return on assets (ROA) for 2024-2026?

(NYSE: DLB) forecast ROA is N/A, which is lower than the forecast US Specialty Business Services industry average of N/A.

What is DLB's Price Target?

According to 1 Wall Street analyst that have issued a 1 year DLB price target, the average DLB price target is $98.00, with the highest DLB stock price forecast at $98.00 and the lowest DLB stock price forecast at $98.00.

The Wall Street analyst predicted that Dolby Laboratories's share price could reach $98.00 by Jan 31, 2025. The average Dolby Laboratories stock price prediction forecasts a potential upside of 22.64% from the current DLB share price of $79.91.

What is DLB's forecast return on equity (ROE) for 2024-2026?

(NYSE: DLB) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.